Won Sik Lee

3.1k total citations
119 papers, 1.0k citations indexed

About

Won Sik Lee is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Won Sik Lee has authored 119 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hematology, 48 papers in Oncology and 37 papers in Pathology and Forensic Medicine. Recurrent topics in Won Sik Lee's work include Lymphoma Diagnosis and Treatment (35 papers), Acute Myeloid Leukemia Research (21 papers) and Multiple Myeloma Research and Treatments (19 papers). Won Sik Lee is often cited by papers focused on Lymphoma Diagnosis and Treatment (35 papers), Acute Myeloid Leukemia Research (21 papers) and Multiple Myeloma Research and Treatments (19 papers). Won Sik Lee collaborates with scholars based in South Korea, United States and Puerto Rico. Won Sik Lee's co-authors include Ho‐Jin Shin, Hawk Kim, Ho Sup Lee, Cheolwon Suh, Je‐Hwan Lee, Young‐Don Joo, Jung‐Hee Lee, Jin Seok Kim, Young Rok and Myung Soo Hyun and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Won Sik Lee

110 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Won Sik Lee South Korea	17	534	328	234	232	187	119	1.0k
Mehmet Turgut Türkiye	15	473 0.9×	204 0.6×	148 0.6×	197 0.8×	102 0.5×	63	834
Ian Nivison‐Smith Australia	18	360 0.7×	280 0.9×	104 0.4×	104 0.4×	88 0.5×	39	868
Olga Graciela Cantú‐Rodríguez Mexico	21	825 1.5×	217 0.7×	106 0.5×	279 1.2×	96 0.5×	98	1.2k
Ove Juul Nielsen Denmark	20	892 1.7×	163 0.5×	133 0.6×	478 2.1×	252 1.3×	44	1.4k
Kris M. Mahadeo United States	20	329 0.6×	461 1.4×	73 0.3×	210 0.9×	217 1.2×	113	1.2k
R. Y. J. Tamminga Netherlands	20	611 1.1×	167 0.5×	75 0.3×	154 0.7×	154 0.8×	67	1.2k
Maria Cristina Tirindelli Italy	19	325 0.6×	356 1.1×	86 0.4×	131 0.6×	135 0.7×	58	1.0k
G. Kollerup Denmark	22	163 0.3×	296 0.9×	183 0.8×	127 0.5×	263 1.4×	43	1.7k
Chiara Crotti Italy	17	176 0.3×	159 0.5×	113 0.5×	148 0.6×	146 0.8×	56	1.1k
Emilian Snarski Poland	14	187 0.4×	127 0.4×	198 0.8×	119 0.5×	116 0.6×	42	806

Countries citing papers authored by Won Sik Lee

Since Specialization

Citations

This map shows the geographic impact of Won Sik Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won Sik Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won Sik Lee more than expected).

Fields of papers citing papers by Won Sik Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won Sik Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won Sik Lee. The network helps show where Won Sik Lee may publish in the future.

Co-authorship network of co-authors of Won Sik Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Won Sik Lee. A scholar is included among the top collaborators of Won Sik Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won Sik Lee. Won Sik Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yhim, Ho‐Young, Yong Park, Jeong‐A Kim, et al.. (2024). Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study. The Korean Journal of Internal Medicine. 39(3). 501–512. 3 indexed citations

Kim, Hyunwoo, Ja Young Lee, Shinae Yu, et al.. (2024). Acute myeloid leukemia and myelodysplastic neoplasms: clinical implications of myelodysplasia-related genes mutations and TP53 aberrations. Blood Research. 59(1). 41–41. 1 indexed citations

Lee, Ji Yun, Ji Hyun Kwon, Joon Young Hur, et al.. (2023). Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea. Cancer Research and Treatment. 56(2). 681–687. 4 indexed citations

Jo, Jae‐Cheol, Young‐Woo Jeon, Deok‐Hwan Yang, et al.. (2023). A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea. Expert Opinion on Biological Therapy. 23(8). 737–747. 1 indexed citations

Park, Ha Young, Minji Kim, Won Hee Jang, et al.. (2022). Aryl hydrocarbon receptor–targeted therapy for CD4+ T cell–mediated idiopathic pneumonia syndrome in mice. Blood. 139(22). 3325–3339. 14 indexed citations

Yoo, Kwai Han, Hyeoung‐Joon Kim, Yoo Hong Min, et al.. (2021). Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry. PLoS ONE. 16(5). e0251011–e0251011. 6 indexed citations

Shin, Hyejin, Dae Young Zang, Sung‐Hyun Kim, et al.. (2021). Appropriate Starting Dose of Dasatinib Based on Analyses of Dose-Limiting Toxicities and Molecular Responses in Asian Patients With Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 21(6). e521–e529. 7 indexed citations

Jung, Sung‐Hoon, Young Rok, Dae Sik Kim, et al.. (2020). Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia. Yonsei Medical Journal. 61(6). 452–452.

Kim, Won Seog, Cheolwon Suh, Jung Yong Hong, et al.. (2019). A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial). Leukemia & lymphoma. 60(13). 3251–3257. 4 indexed citations

10.

Park, Sungwoo, Dong Won Baek, Sang Kyun Sohn, et al.. (2019). Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic Syndrome. Clinical Lymphoma Myeloma & Leukemia. 19(7). e367–e373. 2 indexed citations

11.

Cho, Hee Jeong, Dong Won Baek, Sungwoo Park, et al.. (2018). Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimen. SHILAP Revista de lepidopterología. 35(1). 76–83. 3 indexed citations

12.

Lee, Sang Min, et al.. (2016). Treatment outcomes of IMEP as a front-line chemotherapy for patients with peripheral T-cell lymphomas. Blood Research. 51(3). 187–187.

13.

Kım, Kihyun, Dok Hyun Yoon, Jin Seok Kim, et al.. (2014). Clinical Factors Associated with Response or Survival after Chemotherapy in Patients with Waldenström Macroglobulinemia in Korea. BioMed Research International. 2014. 1–7. 3 indexed citations

14.

Kım, Kihyun, Mark Lee, Hyo Jung Kim, et al.. (2013). Observational Study Of VMP (Bortezomib, melphalan, prednisolone) Regimen For Newly Diagnosed Korean Myeloma Patients Who Are Not Eligible For Transplantation. Blood. 122(21). 5379–5379. 3 indexed citations

15.

Baz, Rachid, Hui‐Yi Lin, Sung‐Soo Yoon, et al.. (2013). Response Adapted Lenalidomide Based Therapy For Newly Diagnosed (ND) Standard Risk Older Adults With Multiple Myeloma (MM): An International Collaboration. Blood. 122(21). 3201–3201. 1 indexed citations

16.

Lee, Je‐Hwan, Yunsuk Choi, Sung-Doo Kim, et al.. (2013). Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome. Annals of Hematology. 92(7). 889–897. 20 indexed citations

17.

Lee, Je‐Hwan, Young‐Don Joo, Hawk Kim, et al.. (2012). Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine. Journal of Clinical Oncology. 31(6). 701–709. 77 indexed citations

18.

Lee, Ja Young, Jae Hyun Kim, Jeong Hwan Shin, et al.. (2008). Primary Isolated Bone Marrow Diffuse Large B-cell Lymphoma with Hemolytic Anemia as the First Manifestation. The Korean Journal of Hematology. 43(1). 48–48. 2 indexed citations

19.

Lee, Won Sik, et al.. (2005). The efficacy of HPV DNA chip test in the atypical squamous cell of undetermined significance. 16(4). 323–323. 1 indexed citations

20.

Lee, Won Sik, June Seek Choi, Hyun Kyong Ahn, et al.. (2002). Surgical Management of Adnexal Mass during Pregnancy. Obstetrics & Gynecology Science. 45(9). 1560–1565. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact